Skip to content

Establishment of Virtual Reality System for Stroke Patients With Aphasia

Establishment of Virtual Reality System for Stroke Patients With Aphasia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05606393
Enrollment
100
Registered
2022-11-04
Start date
2022-04-07
Completion date
2023-10-31
Last updated
2022-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia

Keywords

virtual reality, aphasia, language rehabilitation, stroke

Brief summary

Aphasia can significantly influence a person's social relationship and quality of life. To achieve positive language outcomes, an intensive and high-repetition speech therapy is essential. However, due to the limited number of speech therapists, the intensity and frequency of training are often insufficient. Therefore, it is critical to develop other rehabilitation approaches to enhance the benefits of aphasia intervention. Virtual reality (VR) is an immersive and interactive computer simulation technology that can promote the ecological validity of speech therapy. In this study, we develop an innovative VR software for speech training to explore the effects of VR on various aspects of language outcomes.

Detailed description

We randomly assigned study participants into 2 groups: the traditional speech therapy (ST) group and the traditional ST with additional VR training (ST+VR) group. In the ST group, each participant received 1-hour traditional ST for each session. In the ST+VR group, an additional 30-minute VR training was administered immediately after each session of traditional ST. All participants received 3 sessions of treatment every week for 3 weeks. For outcome measurement, we administered Concise Chinese Aphasia Test (CCAT) at 3 different time points: before treatment, 1 day and 3 months after the completion of treatment.

Interventions

OTHERvirtual reality speech training

virtual reality speech training that focuses on receptive and expressive aspects of language, through a newly developed interactive virtual reality software

traditional speech therapy in current clinical use, that focuses on language comprehension, naming, fluency, repetition.

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of stroke with aphasia, including fluent and non-fluent types * Age between 20\ 80-year-old * Able to understand virtual reality training * Able to cooperate with instructions and follow the rules * Able to use the virtual reality controller and device * Able to sign the subject's informed consent

Exclusion criteria

* Diagnosis of brain pathology other than stoke, such as brain tumor, Parkinson's disease, dementia * Unable to cooperate with the instructions * Unable to learn how to use the virtual reality controller and device * Any medical diseases or unstable vital signs that may cause safety concern * Severe hearing or vision impairments * Have ever received any form of speech therapy or virtual reality training

Design outcomes

Primary

MeasureTime frameDescription
Changes Concise Chinese Aphasia Test (CCAT) scores at 1 day after treatmentBaseline and at 1 day after total treatments completeCCAT total scores and scores of subtests, including conversation, description, matching, listening comprehension, expression, reading recognition, sentence repetition, imitation, spontaneous writing
Changes of Concise Chinese Aphasia Test (CCAT) scores at 3 months after treatmentBaseline and at 3 months after total treatments completeCCAT total scores and scores of subtests, including conversation, description, matching, listening comprehension, expression, reading recognition, sentence repetition, imitation, spontaneous writing

Countries

Taiwan

Contacts

Primary ContactPo-Yi Tsai, MD
pytsai@vghtpe.gov.tw886-2-2871-2121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026